Results 71 to 80 of about 6,010 (179)

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.

, 2004
The efficacy and safety of combining bosentan, an orally active dual endothelin receptor antagonist and epoprostenol, a continuously infused prostaglandin, in the treatment of pulmonary arterial hypertension (PAH) was investigated.
Robbins IM, Rubin LJ, Horn EM, Barst RJ, Channick RN, Simonneau G., MANES, ALESSANDRA, Humbert M, Boonstra A, GALIE', NAZZARENO   +9 more
core   +1 more source

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension Prognostic factors and survival [PDF]

, 2002
ObjectivesWe sought to determine the factors associated with long-term survival in patients with primary pulmonary hypertension (PPH) treated with continuous epoprostenol infusion.BackgroundEpoprostenol improves survival in patients with PPH in New York ...
Rainisio, Maurizio, Nunes, Hilario, Humbert, Marc, Parent, Florence, Sitbon, Olivier, Garcia, Gilles, Hervé, Philippe, Simonneau, G.érald   +7 more
core   +1 more source

Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation

Health Technology Assessment, 2009
Objective(s): To investigate the clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for the treatment of adults with pulmonary arterial hypertension (PAH) within their licensed indications.
Y-F Chen, S Jowett, P Barton, K Malottki, C Hyde, JSR Gibbs, J Pepke-Zaba, A Fry-Smith, J Roberts, D Moore   +9 more
doaj   +1 more source

Addition of a bilateral access form of peripheral extracorporeal membrane oxygenation rescued a patient with idiopathic pulmonary arterial hypertension who developed circulatory collapse immediately after childbirth

Pulmonary Circulation, 2020
Pregnancy is not advised for patients with Pulmonary hypertension (PH) because of high risk of PH crisis. However, some patients have undiagnosed idiopathic pulmonary arterial hypertension (IPAH) before pregnancy.
Shiro Adachi, Shigetake Shimokata, Masahiro Yoshida, Ryo Imai, Yoshihisa Nakano, Naoki Okumura, Susumu Suzuki, Toyoaki Murohara, Takahisa Kondo   +8 more
doaj   +1 more source

Predictors of Outcome in 216 Subjects With ARDS Treated With Inhaled Epoprostenol

, 2013
BACKGROUND: ARDS is an important cause of respiratory failure and continues to be associated with a high mortality rate. Numerous therapeutic interventions have been employed to improve patient outcomes, including inhaled epoprostenol.
Micek, Scott T., H. Arnold, J. Pacheco, P. Watts, Pacheco, Jose, Skrupky, Lee, S. T. Micek, M. H. Kollef, Watts, Peggy, L. Skrupky, Arnold, Heather, Kollef, Marin H.   +11 more
core   +1 more source

Epoprostenol [PDF]

Reactions Weekly, 2020
  +6 more sources

Incidence of Bloodstream Infection in Patients with Pulmonary Hypertension under Intravenous Epoprostenol or Iloprost—A Multicentre, Retrospective Study

, 2023
Intravenous synthetic prostacyclin analogs (iPCAs), such as epoprostenol, treprostinil and iloprost have been widely used for the treatment of pulmonary arterial hypertension (PAH).
Patrícia Marques-Alves, Rui Baptista, Marques-Alves, Patricia, Baptista, Rui, Castro, Graça, Coelho, Francisco das Neves, Graça Castro, Natália Cruz-Martins, Ferreira, Filipa, Camara, Raquel Paulinetti, Cruz-Martins, Natália, Filipa Ferreira, Raquel Paulinetti Camara, Francisco das Neves Coelho   +13 more
core   +1 more source

Efficacy of Inhaled Treprostinil in a Patient with Systemic Sclerosis-Associated Pulmonary Hypertension and Interstitial Lung Diseases Refractory to Conventional Intravenous Epoprostenol

Medicina
Background: Systemic sclerosis-associated pulmonary hypertension (SSc-PH) is widely recognized as the most severe subtype of connective tissue disease-associated pulmonary hypertension (CTD-PH), particularly in patients with complicating factors such as ...
Yuki Hida, Teruhiko Imamura, Ryuichi Ushijima, Koichiro Kinugawa   +3 more
doaj   +1 more source

Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery [PDF]

, 2003
Objective: Pulmonary hypertension is commonly found in patients undergoing valvular surgery and can be worsened by cardiopulmonary bypass. Inhaled epoprostenol (prostacyclin) has been used for the treatment of pulmonary hypertension, but its effects ...
Noël, Nicolas, Dupuis, Jocelyn, Robitaille, Danielle, Couture, Pierre, Babin, Denis, Denault, André, Sheridan, Peter, Guertin, Marie-Claude, Haché, Manon, Pellerin, Michel, Bélisle, Sylvain, Martineau, Raymond   +11 more
core   +1 more source

Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions

, 2004
BACKGROUND: Although patients with primary pulmonary hypertension and patients with chronic thromboembolic pulmonary hypertension with distal lesions may share similar pathophysiological characteristics, scarce information is available on the usefulness ...
Piovella F., Klersy C., Tavazzi L., Campana C., Ghio S., D'ARMINI, ANDREA MARIA, Scelsi L., VIGANO', MARIO, Serio A.   +8 more
core